SUNESIS PHARMACEUTICALS INC's ticker is SNSS and the CUSIP is 867328601. A total of 74 filers reported holding SUNESIS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2015 | $2,016,000 | +82.4% | 669,770 | +48.5% | 0.00% | +100.0% |
| Q1 2015 | $1,105,000 | +3583.3% | 451,090 | +3788.7% | 0.00% | – |
| Q4 2014 | $30,000 | -73.2% | 11,600 | -26.1% | 0.00% | – |
| Q3 2014 | $112,000 | +111.3% | 15,700 | +91.5% | 0.00% | – |
| Q2 2014 | $53,000 | +1225.0% | 8,200 | +1133.1% | 0.00% | – |
| Q1 2014 | $4,000 | -95.3% | 665 | -96.3% | 0.00% | – |
| Q4 2013 | $85,000 | -26.1% | 18,019 | -22.1% | 0.00% | – |
| Q3 2013 | $115,000 | -24.3% | 23,119 | -20.9% | 0.00% | – |
| Q2 2013 | $152,000 | – | 29,243 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 8,250,000 | $7,404,000 | 3.11% |
| BVF INC/IL | 4,777,381 | $4,288,000 | 0.73% |
| NEA Management Company, LLC | 7,789,644 | $7,011,000 | 0.45% |
| Palo Alto Investors LP | 6,974,854 | $6,260,000 | 0.35% |
| Healthcare Value Capital, LLC | 150,000 | $135,000 | 0.22% |
| Frontier Wealth Management LLC | 527,870 | $474,000 | 0.08% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,067,122 | $1,855,000 | 0.06% |
| Baker Brothers Advisors | 4,450,000 | $3,994,000 | 0.03% |
| Noven Financial Group, Inc. | 41,000 | $37,000 | 0.03% |
| FRANKLIN STREET ADVISORS INC /NC | 100,000 | $90,000 | 0.02% |